Dr. Nora Barsony, MD (she/her) is an Endocrinologist in Tucson, AZ with over 15 years of experience. What is your opinion of Dr. Nora Barsony, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Nora Barsony, MD has received over $260,804 which includes payments from the following companies:
$133,929.52 from Novo Nordisk Inc
$61,777.00 from Boehringer Ingelheim Pharmaceuticals, Inc.
$29,167.75 from LILLY USA, LLC
$10,810.38 from sanofi-aventis U.S. LLC
$8,096.39 from Takeda Pharmaceuticals America, Inc.
$3,365.65 from Takeda Pharmaceuticals U.S.A., Inc.
$2,046.39 from AstraZeneca Pharmaceuticals LP
$1,318.54 from Amgen Inc.
$1,139.59 from Corcept Therapeutics
$760.50 from MannKind Corporation
$700.54 from Merck Sharp & Dohme Corporation
$627.37 from Janssen Pharmaceuticals, Inc
$620.99 from Radius Health, Inc.
$616.75 from AbbVie, Inc.
$554.97 from Abbott Laboratories
$420.34 from GlaxoSmithKline, LLC.
$381.78 from AKRIMAX PHARMACEUTICALS, LLC
$371.59 from Valeritas, Inc.
$334.23 from Eisai Inc.
$325.86 from Shire North American Group Inc
Payments received by Dr. Nora Barsony, MD were from the following categories:
$195,631.25 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!